GlassScriptPhysician profile
Michael Vogelbaum
NPI 1598732380
$56,071.45
in general payments reported to CMS, 2019-2025
13 companies · $37.85 in 2025
The $37.85 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,858 · 2020: $136 · 2021: $162 · 2022: $11K · 2023: $11K · 2024: $30K · 2025: $37.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Travel and Lodging: $11K · Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,601.25 |
| Travel and Lodging | $11,066.99 |
| Food and Beverage | $364.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $29,613.84 | 2024 | |
| Servier Pharmaceuticals LLC | $11,356.22 | 2023 | |
| Olympus America INC. | $10,688.68 | 2022 | |
| Blue Earth Diagnostics | $2,750.00 | 2019 | |
| Biogen, INC. | $1,107.70 | 2019 | |
| Olympus Corporation of The Americas | $194.10 | 2022 | |
| Elekta, INC. | $161.83 | 2021 | |
| Zimmer Biomet Holdings, INC. | $120.00 | 2020 | |
| Globus Medical, INC. | $37.85 | 2025 | Creo, Concord, Fortify |
| Illumina, INC. | $24.77 | 2023 | Oncology Testing |
| Brainlab, INC. | $16.46 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vogelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.